Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2012
03/29/2012WO2012040278A1 Sickle confirm modified hemoglobin solubility test
03/29/2012WO2012040264A2 Diagnostic tests for immune reactivity with human endothelial cell growth factor
03/29/2012WO2012040246A2 Biomarkers for growth hormone action
03/29/2012WO2012040226A2 Gene expression in n-cadherin overexpressing prostate cancers and their controls
03/29/2012WO2012040098A2 Methods, systems and devices for forming nanochannels
03/29/2012WO2012040073A2 Biomarkers of renal injury
03/29/2012WO2012040067A2 Method and device for high throughput cell deformability measurements
03/29/2012WO2012040065A1 Grm3 mutations and use thereof for the diagnosis and treatment of melanoma
03/29/2012WO2012040059A2 Compositions and methods for modulating desnutrin-mediated adipocyte lipolysis
03/29/2012WO2012040050A1 System and method for determining ambient temperatures for a fluid analyte system
03/29/2012WO2012039779A1 Humanized transgenic mouse model
03/29/2012WO2012039759A2 Multimedia evaluation of butanol-containing fuels
03/29/2012WO2012039614A1 Novel method for diagnosing lyme disease using a cellular immunological test
03/29/2012WO2012039529A1 Detection of target nucleic acid sequences by exonucleolytic activity using single-labeled immobilized probes on solid phase
03/29/2012WO2012039520A1 Transducer and method for manufacturing same
03/29/2012WO2012039513A1 Proliferation, separation and transplantation of suppressive neural progenitor cells, and substance capable of enhancing proliferation of the cells
03/29/2012WO2012039481A1 Method for detecting mutant dna
03/29/2012WO2012039469A1 Method for screening binding inhibitor of rage and age
03/29/2012WO2012039430A1 Method for isolating cancer stem cells
03/29/2012WO2012039422A1 Method and device for detecting nucleic acid, and kit
03/29/2012WO2012039261A1 Method for screening half-dry smell deodorizer and method for evaluating half-dry smell deodorizer
03/29/2012WO2012039161A1 Novel testing method and testing reagent for angiitis
03/29/2012WO2012039129A1 Filter device
03/29/2012WO2012039097A1 Cell analyzer
03/29/2012WO2012038932A2 Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
03/29/2012WO2012038929A1 Cosmetic use of dermicidin, and analogues or fragments thereof
03/29/2012WO2012038820A2 Immunochromatography devices, methods and kits
03/29/2012WO2012038769A1 Measuring apparatus for determining flowing properties of polymeric melts
03/29/2012WO2012038574A1 Method for diagnosing an eye allergy in a child
03/29/2012WO2012038541A1 Diagnostic method for bacterial meningitis
03/29/2012WO2012038525A1 Cancer phospholipidome
03/29/2012WO2012038505A1 Breast cancer diagnostics
03/29/2012WO2012038486A1 Method for obtaining a purified hbha polypeptide or fragment thereof
03/29/2012WO2012038470A2 Method for the detection of fat-soluble vitamins
03/29/2012WO2012038463A2 Use of myeloid cell biomarkers for the diagnosis of cancer
03/29/2012WO2012038370A1 Method for the detection and/or quantification of the interaction of platelets with interaction partners
03/29/2012WO2012038331A1 Assay for a type ii collagen biomarker
03/29/2012WO2012038310A1 Method for regulating the formation of a fibrous web
03/29/2012WO2012038068A2 Means and methods for the prediction of treatment response of a cancer patient
03/29/2012WO2012037974A1 Determination of attributes of liquid substances
03/29/2012WO2012037928A2 Compounds for the diagnosis of neurodegenerative disorders on the olfactory epithelium
03/29/2012WO2012037667A1 Synthesis of fluorescent noble metal nanoparticles
03/29/2012WO2012037659A1 System for molecular packing calculations
03/29/2012WO2012037631A1 Fuel composition identification system and method and fluid composition identification method
03/29/2012WO2012037609A1 Serum preparation
03/29/2012WO2012037603A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions
03/29/2012WO2012017116A3 Method for producing biosensors
03/29/2012WO2012012019A3 Microsensor for mercury
03/29/2012WO2012010654A3 Immmunomagnetic complex and its use in red blood cell grouping/phenotyping
03/29/2012WO2012001351A4 Hand-held test meter with deep power conservation mode
03/29/2012WO2011163627A3 Organ specific diagnostic panels and methods for identification of organ specific panel proteins
03/29/2012WO2011159741A3 Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same
03/29/2012WO2011158037A3 Methods for direct pcr using a polymeric material as sample carrier
03/29/2012WO2011156707A3 Alternative nucleotide flows in sequencing-by-synthesis methods
03/29/2012WO2011154139A3 Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
03/29/2012WO2011152883A3 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
03/29/2012WO2011144914A3 Diagnostic methods
03/29/2012WO2011143340A3 Use of nanopore arrays for multiplex sequencing of nucleic acids
03/29/2012WO2011140093A3 Detection and monitoring of nonalcoholic fatty liver disease
03/29/2012WO2011139972A3 Apparatus, method and system for generating optical radiation from biological gain media
03/29/2012WO2011139733A3 Immune and oxygen system measuring and drug screening method and apparatus
03/29/2012WO2011130647A3 Compositions and methods for characterizing a myopathy
03/29/2012WO2011128893A3 Device, system and method for rapid determination of a medical condition
03/29/2012WO2011119986A9 Methods for culturing and analyzing cells
03/29/2012WO2011112993A3 Methods of predicting and decreasing the risk of pregnancy loss
03/29/2012WO2011112929A3 Magnetic sensor based quantitative binding kinetics analysis
03/29/2012WO2008130887A8 Biomarkers for follicular thyroid carcinoma and methods of of use
03/29/2012US20120079616 Npc1l1 (npc3) and methods of use thereof
03/29/2012US20120079614 Cd109 polypeptides and uses thereof for the treatment of skin cells
03/29/2012US20120079611 Tl1a model of inflammation fibrosis and autoimmunity
03/29/2012US20120078529 Determining the severity of 5-fluorouracil overdose
03/29/2012US20120078524 System and method for diagnosis tissue samples using fluorescence and raman techniques
03/29/2012US20120078523 Methods for isolation and viability assessment of biological organisms
03/29/2012US20120078073 Analyte Sensors and Methods of Use
03/29/2012US20120077843 Malignant precursor cells from ductal carcinoma in situ lesions
03/29/2012US20120077831 Methods and assays for the treatment of irritable bowel syndrome
03/29/2012US20120077792 Lanthanide metal complexes useful in treating cancer
03/29/2012US20120077758 Infertility associated defb-126 deletion polymorphism
03/29/2012US20120077750 Use of a growth-stimulating protein
03/29/2012US20120077734 Methods and assays for treating conditions in which macrophages play a pathogenic role
03/29/2012US20120077714 Mass Spectrometry Based Particle Separation
03/29/2012US20120077711 Novel Ligands and Libraries of Ligands
03/29/2012US20120077709 Biomarkers for Differentiating Between Type 1 and Type 2 Diabetes
03/29/2012US20120077708 Beta-2 microglobulin as a biomarker for peripheral artery disease
03/29/2012US20120077706 Method for assaying protein-protein interaction
03/29/2012US20120077705 Methods for Identifying Autophagy Inducing Compounds
03/29/2012US20120077694 Targets in breast cancer for prognosis or therapy
03/29/2012US20120077693 Method and kit for establishing an in vitro prognosis on a patient exhibiting sirs
03/29/2012US20120077690 Biomarkers of renal injury
03/29/2012US20120077689 Compartment-Specific Non-HLA Targets for Diagnosis and Prediction of Graft Outcome
03/29/2012US20120077682 Compositions and methods for detecting cancer metastasis
03/29/2012US20120077286 Highly sensitive immunoassay systems for detecting multiple allergens
03/29/2012US20120077285 Layering for separating particles
03/29/2012US20120077284 Binding Surfaces for Affinity Assays
03/29/2012US20120077280 Nanofibers with modified optical properties
03/29/2012US20120077277 Analyte Meter Protectors and Methods
03/29/2012US20120077276 Methods of determining potency of chemically-synthesized oligonucleotides
03/29/2012US20120077261 Device for a membrane assay
03/29/2012US20120077212 Methods of diagnosing als
03/29/2012US20120077211 Stable compositions comprising chromogenic compounds and methods of use
1 ... 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 ... 3937